Cargando…
High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission
The recent impact of Ebola virus disease (EVD) on public health in Africa clearly demonstrates the need for a safe and efficacious vaccine to control outbreaks and mitigate its threat to global health. ERVEBO® is an effective recombinant Vesicular Stomatitis Virus (VSV)-vectored Ebola virus vaccine...
Autores principales: | Morozov, Igor, Monath, Thomas P., Meekins, David A., Trujillo, Jessie D., Sunwoo, Sun-Young, Urbaniak, Kinga, Kim, In Joong, Narayanan, Sanjeev K., Indran, Sabarish V., Ma, Wenjun, Wilson, William C., O'Connor, Cassandra, Dubey, Sheri, Troth, Sean P., Coller, Beth-Ann, Nichols, Richard, Martin, Brian K., Feldmann, Heinz, Richt, Juergen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023602/ https://www.ncbi.nlm.nih.gov/pubmed/33719915 http://dx.doi.org/10.1080/22221751.2021.1903343 |
Ejemplares similares
-
Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
por: Marzi, Andrea, et al.
Publicado: (2015) -
The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials
por: Suder, Ellen, et al.
Publicado: (2018) -
rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment
por: Monath, Thomas P., et al.
Publicado: (2019) -
The synthetic futures of vesicular stomatitis virus
por: Overend, Christopher, et al.
Publicado: (2012) -
Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
por: Geisbert, Thomas W., et al.
Publicado: (2008)